Cargando…
Biologics Targeting in the Treatment of Inflammatory Bowel Disease: A Conundrum
Inflammatory bowel disease is a chronic, gastrointestinal disorder which is classified into Crohns’ disease and ulcerative colitis. It has a strong effect on the quality of life and is characterized by chronic periods of exacerbation and remission. It has an unknown etiology but is driven due to exc...
Autores principales: | Rehman, Mahnoor, Cancarevic, Ivan, Iskander, Beshoy, Lalani, Sanee, Malik, Bilal Haider |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584287/ https://www.ncbi.nlm.nih.gov/pubmed/33123434 http://dx.doi.org/10.7759/cureus.10621 |
Ejemplares similares
-
Is There a Correlation Between Irritable Bowel Syndrome and Lactose Intolerance?
por: Cancarevic, Ivan, et al.
Publicado: (2020) -
Use of Rituximab in Management of Rapidly Progressive Glomerulonephritis
por: Cancarevic, Ivan, et al.
Publicado: (2020) -
Uncommon Presentations of Multiple Myeloma
por: Tathineni, Praveena, et al.
Publicado: (2020) -
Thyrotoxic Periodic Paralysis With Features of Andersen-Tawil Syndrome: A Case Report and Literature Review
por: Iskander, Beshoy, et al.
Publicado: (2020) -
Role of Substance P in the Pathophysiology of Inflammatory Bowel Disease and Its Correlation With the Degree of Inflammation
por: Patel, Mauli, et al.
Publicado: (2020)